The 2014 Heart Rhythm Society Scientific Sessions ended May 10 in San Francisco with a big study from Boston Scientific on the benefits of implantable cardioverter defibrillator remote monitoring, and data on a smartphone-enabled electrocardiogram and the use of a spinal stimulator for heart failure patients. Earlier in the meeting, data were reported on the success of pacemaker remote monitoring and other studies.

At this year's Heart Rhythm Society meeting, companies showcased a number of technologies designed to make cardiac rhythm management (CRM) devices, such as implantable cardioverter defibrillators and pacemakers, safer, more effective, and easier to implant. In addition, there were some early-stage presentations on promising next-generation CRM technologies involving leadless and rechargeable systems-paradigm changing advances.